U.S. stocks were lower, with the Dow Jones index falling around 650 points on Monday.



Shares of Relmada Therapeutics Inc (NASDAQ:RLMD) rose sharply during Monday's session following the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer.



The 12-month interim data from the ongoing Phase 2 trial showed a complete response rate of 76%, with an impressive 80% in the BCG-unresponsive patient population.



Relmada Therapeutics shares jumped 40.8% to $6.27 on Monday.



Here are some other big stocks recording gains in today’s session.



<ul>
<li>Hims &amp; Hers Health Inc (NYSE:HIMS) shares jumped 42.6% to $22.44 after reports suggested that the company has agreed with Novo Nordisk to market weight-loss drugs from the Danish drugmaker on the Hims platform. Also, Novo Nordisk dropped its patent infringement case against the company.</li>



<li>Xenon Pharmaceuticals Inc (NASDAQ:XENE) gained 42% to $59.53 following the announcement of positive topline results from the Phase 3 X-TOLE2 study of azetukalner in focal onset seizures.</li>



<li>W&amp;T Offshore, Inc. (NYSE:WTI) shares jumped 27.4% to $4.00.</li>



<li>Dianthus Therapeutics Inc (NASDAQ:DNTH) gained 26.7% to $82.62 following an early GO decision announced by the company based on an interim responder analysis in the Phase 3 CAPTIVATE trial of claseprubart in chronic inflammatory demyelinating polyneuropathy (CIDP).</li>



<li>Uniqure NV (NASDAQ:QURE) gained 21.1% to $17.28 after news that Dr. Vinay Prasad will step down from leading the U.S. Food and Drug Administration's biologics division.</li>



<li>Solid Biosciences Inc (NASDAQ:SLDB) shares rose 20% to $8.10.</li>



<li>Regenxbio Inc (NASDAQ:RGNX) shares jumped 18.7% to $10.26.</li>



<li>Kingsoft Cloud Holdings Ltd (NASDAQ:KC) shares climbed 14.3% to $13.70.</li>



<li>Garden Stage Ltd (NASDAQ:GSIW) shares climbed 10.2% to $10.51.</li>



<li>Dyne Therapeutics Inc (NASDAQ:DYN) gained 10.2% to $16.37. Dyne Therapeutics said it initiated Phase 3 HARMONIA trial of Zeleciment Basivarsen (Z-basivarsen, DYNE-101) For Myotonic Dystrophy Type 1.</li>



<li>Lumentum Holdings Inc (NASDAQ:LITE) gained 9.2% to $609.76.</li>



<li>Circle Internet Group Inc (NYSE:CRCL) gained 8.7% to $110.80.</li>



<li>United Therapeutics Corp (NASDAQ:UTHR) shares climbed 6.8% to $510.51. United Therapeutics announced a $2 billion stock repurchase authorization and enters into $1.5 billion accelerated share repurchase program.</li>



<li>StubHub Holdings Inc (NYSE:STUB) gained 6.7% to $8.92.</li>



<li>Denali Therapeutics Inc (NASDAQ:DNLI) shares surged 6.6% to $21.00.</li>
</ul>



Photo via Shutterstock

UTHR

U.S. stocks fell sharply, with the Dow dropping 650 points. However, Relmada Therapeutics saw a significant rise of 40.8% to $6.27 after positive Phase 2 trial results for its cancer treatment. Other notable gainers included Hims & Hers (+42.6%), Xenon Pharmaceuticals (+42%), and Dianthus Therapeutics (+26.7%). United Therapeutics announced a $2 billion stock repurchase program, contributing to its 6.8% increase. Overall, several stocks experienced substantial gains despite the broader market decline.

benzinga_article

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

United Therap

Xenon Pharma

Invesco Biotechnology & Genome ETF

iShares US Pharma

Dianthus Therapeutics

Hims & Hers Health

Relmada Therapeutics

iShares Biotechnology ETF

VanEck Biotech ETF

Ark Genomic Revolution ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday